Quarterly report pursuant to Section 13 or 15(d)

Supplemental Disclosure of Cash Flow Information (Tables)

v3.20.2
Supplemental Disclosure of Cash Flow Information (Tables)
9 Months Ended
Sep. 30, 2020
Supplemental Cash Flow Elements [Abstract]  
Schedule of Supplemental Cash Flow Information
    Nine Months Ended September 30,  
    2020     2019  
Cash paid for interest   $ 64,454     $ -  
Cash paid for income taxes   $ -     $ 45,000  
                 
Acquisition of Jellico Community Hospital and CarePlus Center:                
Inventory   $ -     $ 317,427  
Property and equipment     -       500,000  
Intangible assets     -       250,000  
Accrued expenses     -       158,890  
                 
Non-cash investing and financing activities:                
Series I-2 Preferred Stock converted into common stock   $ 277,994     $ 1,143,973  
Issuance of Series M Preferred Stock in exchange for related party loans and accrued interest     22,000,000       -  
Loans and accrued interest exchanged for Series M Preferred Stock     (18,849,632 )     -  
Issuance of Series N Preferred Stock in exchange for debentures, accrued interest and Series I-1 and Series I-2 Preferred Stock     30,435,519       -  
Debentures, accrued interest and Series I-1 and Series I-2 Preferred Stock exchanged for Series N Preferred Stock     (19,342,322 )     -  
Series N Preferred Stock converted into common stock     58       -  
Deemed dividends     66,695,318       123,861,587  
Exchange of Series K Preferred Stock for Series L Preferred Stock     (2,500 )     -  
Issuance of Series L Preferred Stock     2,500       -  
Original issue discounts on debt     108,958       100,000